Category: Politics and Legislation

Today’s review paper is a look at views on aging on the other side of the world, a counterpoint to commentaries from US and European sources. It is interesting to...

I am generally in favor of the sentiment offered in this commentary on recent clinical trial failures for the first attempts to guide anti-aging technologies through the FDA gauntlet, which...